567 related articles for article (PubMed ID: 27840152)
21. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
22. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
[TBL] [Abstract][Full Text] [Related]
23. The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock.
Ishimaru K; Nakajima S; Yu G; Nakamura Y; Nakao A
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847374
[TBL] [Abstract][Full Text] [Related]
24. The Role of Lipin-1 in the Regulation of Fibrogenesis and TGF-β Signaling in Hepatic Stellate Cells.
Jang CH; Kim KM; Yang JH; Cho SS; Kim SJ; Shin SM; Cho IJ; Ki SH
Toxicol Sci; 2016 Sep; 153(1):28-38. PubMed ID: 27345520
[TBL] [Abstract][Full Text] [Related]
25. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
Yu HX; Yao Y; Bu FT; Chen Y; Wu YT; Yang Y; Chen X; Zhu Y; Wang Q; Pan XY; Meng XM; Huang C; Li J
Mol Immunol; 2019 Mar; 107():29-40. PubMed ID: 30639476
[TBL] [Abstract][Full Text] [Related]
26. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl
He C; Shu B; Zhou Y; Zhang R; Yang X
Life Sci; 2021 Jul; 276():119294. PubMed ID: 33675896
[TBL] [Abstract][Full Text] [Related]
27. Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
Xiu AY; Ding Q; Li Z; Zhang CQ
Drug Des Devel Ther; 2021; 15():3643-3659. PubMed ID: 34456560
[TBL] [Abstract][Full Text] [Related]
28. SR9009 has REV-ERB-independent effects on cell proliferation and metabolism.
Dierickx P; Emmett MJ; Jiang C; Uehara K; Liu M; Adlanmerini M; Lazar MA
Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12147-12152. PubMed ID: 31127047
[TBL] [Abstract][Full Text] [Related]
29. p70 Ribosomal Protein S6 Kinase Is a Checkpoint of Human Hepatic Stellate Cell Activation and Liver Fibrosis in Mice.
Reiter FP; Ye L; Ofner A; Schiergens TS; Ziesch A; Brandl L; Ben Khaled N; Hohenester S; Wimmer R; Artmann R; He Y; Lee SML; Mayr D; Zhang C; Gerbes AL; Mayerle J; Denk G; De Toni EN
Cell Mol Gastroenterol Hepatol; 2022; 13(1):95-112. PubMed ID: 34537439
[TBL] [Abstract][Full Text] [Related]
30. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis.
Yang JH; Kim KM; Cho SS; Shin SM; Ka SO; Na CS; Park BH; Jegal KH; Kim JK; Ku SK; Lee HJ; Park SG; Cho IJ; Ki SH
Antioxid Redox Signal; 2019 Jul; 31(3):243-259. PubMed ID: 30909713
[No Abstract] [Full Text] [Related]
32. Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
Hong L; Shejiao D; Fenrong C; Gang Z; Lei D
J Cell Mol Med; 2015 Oct; 19(10):2462-8. PubMed ID: 26249143
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of eIF3a attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
He P; Yu ZJ; Sun CY; Jiao SJ; Jiang HQ
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):107-11. PubMed ID: 27262813
[TBL] [Abstract][Full Text] [Related]
35. Sestrin 2 Attenuates Rat Hepatic Stellate Cell (HSC) Activation and Liver Fibrosis via an mTOR/AMPK-Dependent Mechanism.
Hu YB; Ye XT; Zhou QQ; Fu RQ
Cell Physiol Biochem; 2018; 51(5):2111-2122. PubMed ID: 30522100
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258.
Liu Y; Wen XM; Lui EL; Friedman SL; Cui W; Ho NP; Li L; Ye T; Fan ST; Zhang H
Lab Invest; 2009 Oct; 89(10):1152-60. PubMed ID: 19668241
[TBL] [Abstract][Full Text] [Related]
37. Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt.
Han CY; Koo JH; Kim SH; Gardenghi S; Rivella S; Strnad P; Hwang SJ; Kim SG
Nat Commun; 2016 Dec; 7():13817. PubMed ID: 28004654
[TBL] [Abstract][Full Text] [Related]
38. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H
J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716
[TBL] [Abstract][Full Text] [Related]
39. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
40. Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.
Xuanfei L; Hao C; Zhujun Y; Yanming L; Jianping G
Oncotarget; 2017 Mar; 8(13):21015-21030. PubMed ID: 28423499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
